Meijer et al. demonstrated that targeting HIF-1 and tumor glucose metabolism at several levels reduced the antioxidant capacity of tumors, affected the tumor microenvironment, and sensitized various solid tumors to irradiation37. The gene discussed is HIF1A; the disease is neoplasm.